首页> 外国专利> NEUROPROTECTION BY PHARMACOLOGICAL CHAPERONING OF NICOTINIC ACETYLCHOLINE RECEPTORS

NEUROPROTECTION BY PHARMACOLOGICAL CHAPERONING OF NICOTINIC ACETYLCHOLINE RECEPTORS

机译:烟碱乙酰胆碱受体的药理作用对神经的保护

摘要

A method of ameliorating an endoplasmic reticulum (ER) stress response and/or unfolded protein response (UPR) in cells expressing nicotinic acetylcholine receptors (nAChRs) comprises contacting a cell expressing nAChRs with an effective amount of a ligand for nAChRs. The contacting results in attenuating endogenously expressed ATF6 translocation, expression of XBP1, phosphorylation of eukaryotic initiation factor 2α (peIF2α), increased numbers of ER exit sites, increased trafficking of known associated proteins as well as other proteins such as growth factors and their receptors, changes in abundance of selected mRNA species, and phosphorylation, abundance, or subcellular compartmentalization of other proteins involved with ER stress and/or the UPR, and inhibiting upregulation of CCAAT/Enhancer-Binding Protein Homologous Protein (CHOP) levels in the cells. The method can be used to screen for neuropharmacotherapeutic agents and to treat or prevent neurodegenerative disease, such as amyotrophic lateral sclerosis (ALS), Parkinson's disease, Alzheimer's disease, or cognitive deficiency.
机译:一种改善表达烟碱样乙酰胆碱受体(nAChRs)的细胞内质网(ER)应激反应和/或未折叠蛋白反应(UPR)的方法,该方法包括使表达nAChRs的细胞与有效量的nAChRs配体接触。接触导致减弱内源性表达的ATF6易位,XBP1的表达,真核起始因子2α(peIF2α)的磷酸化,ER出口位点的数量增加,已知相关蛋白以及其他蛋白(例如生长因子及其受体)的运输增加,选定的mRNA种类的丰度变化,以及与ER应激和/或UPR有关的其他蛋白质的磷酸化,丰度或亚细胞区室化,并抑制细胞中CCAAT /增强子结合蛋白同源蛋白(CHOP)水平的上调。该方法可用于筛选神经药物和治疗或预防神经退行性疾病,例如肌萎缩性侧索硬化症(ALS),帕金森氏病,阿尔茨海默氏病或​​认知障碍。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号